RSM Mexico will join RSM’s transatlantic platform with entities already in the U.S., the U.K., Canada and Ireland, as well as teams in India and El Salvador.
The finance AI conversation has been dominated by capability. The next one is about governance, and most of the agents shipping in 2026 will not survive it.
If you have clients with college-age children earning money from their name, image and likeness, are they responsible enough to handle it and protect it?
The proposal, which would impose a one-time 5% tax on a billionaire’s net worth, has become one of the most closely watched political fights in California.
French President Emmanuel Macron refused to drop the country’s digital tax after Donald Trump threatened new tariffs, setting the stage for a confrontation.
Neumora Therapeutics is laying off 35% of workers after its most advanced asset failed a pair of Phase 3 studies, sending the biotech’s stock spiraling early Monday.
Weeks after Boehringer Ingelheim and Eli Lilly retracted billions of dollar in German commitments, the nation’s government is reportedly changing a contentious element of its planned healthcare reforms.
Intellia Therapeutics’s Senior Vice President Maria Natale discusses why the most successful launches are shaped long before approval, with strategy, structure and patient insight at the core.